Literature DB >> 9670612

Saporin immunotoxins.

D J Flavell1.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9670612     DOI: 10.1007/978-3-642-72153-3_4

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  11 in total

1.  Depletion of cholinergic amacrine cells by a novel immunotoxin does not perturb the formation of segregated on and off cone bipolar cell projections.

Authors:  Emine Gunhan; Prabhakara V Choudary; Thomas E Landerholm; Leo M Chalupa
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

Review 2.  The design of guanidinium-rich transporters and their internalization mechanisms.

Authors:  Paul A Wender; Wesley C Galliher; Elena A Goun; Lisa R Jones; Thomas H Pillow
Journal:  Adv Drug Deliv Rev       Date:  2007-11-09       Impact factor: 15.470

3.  Pharmacodynamics, tissue distribution, toxicity studies and antitumor efficacy of the vascular targeting fusion toxin VEGF121/rGel.

Authors:  Khalid A Mohamedali; Gang Niu; Troy A Luster; Philip E Thorpe; Haokao Gao; Xiaoyuan Chen; Michael G Rosenblum
Journal:  Biochem Pharmacol       Date:  2012-09-26       Impact factor: 5.858

4.  Depleting syndecan-4+ T lymphocytes using toxin-bearing dendritic cell-associated heparan sulfate proteoglycan-dependent integrin ligand: a new opportunity for treating activated T cell-driven disease.

Authors:  Hideo Akiyoshi; Jin-Sung Chung; Mizuki Tomihari; Ponciano D Cruz; Kiyoshi Ariizumi
Journal:  J Immunol       Date:  2010-02-22       Impact factor: 5.422

5.  Delivery of ribosome-inactivating protein toxin into cancer cells with shock waves.

Authors:  Tetsuya Kodama; Apostolos G Doukas; Michael R Hamblin
Journal:  Cancer Lett       Date:  2003-01-10       Impact factor: 8.679

Review 6.  Immunotoxins and other conjugates containing saporin-s6 for cancer therapy.

Authors:  Letizia Polito; Massimo Bortolotti; Manuela Pedrazzi; Andrea Bolognesi
Journal:  Toxins (Basel)       Date:  2011-06-22       Impact factor: 4.546

7.  Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.

Authors:  D J Flavell; D A Boehm; A Noss; S L Warnes; S U Flavell
Journal:  Br J Cancer       Date:  2001-02       Impact factor: 7.640

8.  Polymyxins Facilitate Entry into Mammalian Cells.

Authors:  Kristina M Hamill; Lisa S McCoy; Ezequiel Wexselblatt; Jeffrey D Esko; Yitzhak Tor
Journal:  Chem Sci       Date:  2016-04-25       Impact factor: 9.825

9.  Identification of Prostaglandin F2 Receptor Negative Regulator (PTGFRN) as an internalizable target in cancer cells for antibody-drug conjugate development.

Authors:  Jorge Marquez; Jianping Dong; Chun Dong; Changsheng Tian; Ginette Serrero
Journal:  PLoS One       Date:  2021-01-27       Impact factor: 3.240

10.  Upregulation of p75NTR by Histone Deacetylase Inhibitors Sensitizes Human Neuroblastoma Cells to Targeted Immunotoxin-Induced Apoptosis.

Authors:  Simona Dedoni; Alessandra Olianas; Barbara Manconi; Maria Collu; Barbara Tuveri; Maria Elena Vincis; Maria C Olianas; Pierluigi Onali
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.